Literature DB >> 19470076

Guidelines for the diagnosis and treatment of dermatitis herpetiformis.

M Caproni1, E Antiga, L Melani, P Fabbri.   

Abstract

Dermatitis herpetiformis is a rare disease that should be considered the cutaneous expression of a gluten-sensitive enteropathy indistinguishable from celiac disease. Dermatitis herpetiformis is often misdiagnosed and to date no guidelines for the management of dermatitis herpetiformis have been published in Literature. The present guidelines have been prepared for dermatologists by the Group for Cutaneous Immunopathology of the Italian Society of Dermatology and Venereology. They reflect the best data available at the time of preparation and the clinical experience of the authors and the members of the Italian Group for Cutaneous Immunopathology. The diagnosis of dermatitis herpetiformis is established clinically, histologically, immunopathologically and serologically. A gluten-free diet (GFD) is the treatment of choice for patients with dermatitis herpetiformis. Dapsone and/or other drugs should be used during the period until the GFD is effective. In conclusion, the present guidelines provide evidence-based guidance for the diagnosis and treatment of dermatitis herpetiformis.

Entities:  

Mesh:

Year:  2009        PMID: 19470076     DOI: 10.1111/j.1468-3083.2009.03188.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  41 in total

1.  Celiac disease: a challenge for all physicians.

Authors:  Srihari Mahadov; Peter H R Green
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

Review 2.  [Molecular diagnosis of autoimmune dermatoses].

Authors:  K Hoffmann; M Hertl; C Sitaru
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

3.  Dermatitis herpetiformis: relevance of the physical examination to diagnosis suspicion.

Authors:  Paulo Ricardo Criado; Roberta Fachini Jardim Criado; Valeria Aoki; Walter Belda; Ilana Halpern; Gilles Landman; Cidia Vasconcellos
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

4.  Letter to the editor: Application of dapsone 5% gel in a patient with dermatitis herpetiformis.

Authors:  Marc Z Handler; Anna H Chacon; Michael I Shiman; Lawrence A Schachner
Journal:  J Dermatol Case Rep       Date:  2012-12-31

Review 5.  Clinical and diagnostic aspects of gluten related disorders.

Authors:  Francesco Tovoli; Chiara Masi; Elena Guidetti; Giulia Negrini; Paola Paterini; Luigi Bolondi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

6.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

Review 7.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

8.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 9.  Coeliac disease and autoimmune disease-genetic overlap and screening.

Authors:  Knut E A Lundin; Cisca Wijmenga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-25       Impact factor: 46.802

Review 10.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.